Kathleen R. Bartemes

Mayo Clinic

Papers

1

Total Citations

4

H-Index

1

About

Dr. Kathleen R. Bartemes is a leading investigator in head and neck oncology, with a primary focus on human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). Her most impactful work centers on the clinical utility of circulating tumor HPV DNA (ctHPVDNA) as a dynamic biomarker for disease detection and post-treatment surveillance. In her seminal 2025 study, Dr. Bartemes characterized the early postoperative kinetics of ctHPVDNA clearance, providing critical insights into how rapidly this biomarker declines after surgical resection. This work, which has already garnered significant attention, establishes a foundational timeline for interpreting ctHPVDNA levels in the immediate postoperative period, enabling more precise risk stratification and earlier identification of residual disease. Her contributions are helping to refine non-invasive monitoring strategies, potentially reducing the need for invasive biopsies and imaging in HPV-positive OPSCC patients. With her research directly informing clinical decision-making in a rapidly evolving field, Dr. Bartemes is shaping the future of personalized, biomarker-driven care for patients with HPV-related head and neck cancers.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Postoperative ctHPVDNA Kinetics in Patients With HPV-Related Oropharyngeal Cancer
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago